Target- |
MechanismBacteria replacements [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date14 Sep 2004 |
100 Clinical Results associated with Chengdu Jinxing Jiankang Pharmaceutical Co Ltd
0 Patents (Medical) associated with Chengdu Jinxing Jiankang Pharmaceutical Co Ltd
100 Deals associated with Chengdu Jinxing Jiankang Pharmaceutical Co Ltd
100 Translational Medicine associated with Chengdu Jinxing Jiankang Pharmaceutical Co Ltd